News

Many patients with diabetic foot infections get unnecessary MRSA treatment


 

FROM PLOS ONE

References

Many patients with diabetic foot infections receive methicillin-resistant Staphylococcus aureus antibiotics unnecessarily, according to Kelly Reveles, PharmD, and her associates.

Among the 318 patients with diabetic foot infections (DFIs) in the study, S. aureus was the most common pathogen, accounting for 146 cases. MRSA accounted for 47 of S. aureus cases, and 15% of overall cases. Although MRSA accounted for a relatively small number of cases, MRSA antibiotics were administered to 86% of all patients, resulting in 71% of all patients receiving the treatment unnecessarily.

©Balkonsky/Thinkstock

Independent risk factors for MRSA DFI were male sex and bone involvement. Other risk factors included previous MRSA infection, more severe infection, and a higher white cell count. The most common comorbidities of DFI were hypertension, dyslipidemia, and obesity.

“The improper use of antibiotics unnecessarily exposes the patient to potential complications of the therapy. Furthermore, the overuse of antibiotics drives antimicrobial resistance and is likely to increase the health care burden,” the investigators wrote.

Find the full study in PLoS One (doi: 10.1371/journal.pone.0161658).

lfranki@frontlinemedcom.com

Recommended Reading

United States nears 1,400 cases of Zika in pregnant women
MDedge Dermatology
CDC reports asymptomatic Zika transmission; FDA begins universal blood testing
MDedge Dermatology
Antipsychotic agents key for treating delusional infestation
MDedge Dermatology
Thick Scaly Plaques on the Wrists, Knees, and Feet
MDedge Dermatology
Another 199 pregnant women with Zika
MDedge Dermatology
Treat bed bug bites with topical steroids
MDedge Dermatology
FDA rule will pull many consumer antibacterial soaps from market
MDedge Dermatology
Parents support school-based HPV vaccination
MDedge Dermatology
Zika’s not the only mosquito-borne virus to worry about
MDedge Dermatology
WHO updates ranking of critically important antimicrobials
MDedge Dermatology